Healthcare attracts a lot of “AI funding” talk, but the reality is specific: most money flows through research and NHS programmes, and the harder gate is compliance, not cash. Here’s an honest 2026 guide, cited to official sources. (dgm implements osFoundry as an independent partner.)

Where healthcare AI funding actually sits

There’s no simple “buy AI” grant for healthcare providers. Funding skews toward:

  • Research funders — UKRI, NIHR and similar, mostly to universities and research collaborations (businesses join as partners).
  • NHS national programmes — investment flows through NHS England priorities rather than open SME grants.
  • Innovation routes — Innovate UK competitions where a healthcare AI project is genuinely novel.
  • R&D tax relief — for companies genuinely developing healthcare AI (merged scheme).

The 10 Year Health Plan sets direction

The Fit for the Future: 10 Year Health Plan for England (July 2025) names data, AI, genomics, wearables and robotics as five priority transformative technologies. That signals sustained national investment and direction — shaping where NHS digital money goes, rather than creating a direct SME grant. It’s the strategic backdrop to any NHS AI conversation.

The harder gate: compliance, not cash

For healthcare specifically, compliance is usually the bigger barrier than funding. NHS adoption is gated by:

  • DTAC (Digital Technology Assessment Criteria) — the national baseline covering clinical safety, data protection, technical security, interoperability and usability;
  • Information Governance and the Data Security and Protection Toolkit (DSPT); and
  • MHRA regulation where AI is used for a medical purpose (it’s then a regulated medical device).

A tool can be funded and still fail to deploy if it doesn’t meet these. So the smart move is to build for DTAC/IG from the start — which is as much an implementation decision as a funding one.

Where osFoundry and dgm fit

dgm scopes and implements healthcare AI on osFoundry with an NHS-grade approach: data control (self-host in your own cloud or an EU region — osFoundry publishes US/EU/JP regions, not a UK one), audit logging, and human oversight built in. Patient data is special-category data, so we’d design around IG and DSPT expectations. For non-clinical use cases — admin, correspondence triage, knowledge retrieval — the path is faster; clinical/diagnostic AI brings MHRA into scope.

dgm is an independent integration partner with zero integrations so far; it doesn’t write funding bids, and clinical responsibility and medical-device compliance stay with the provider. To scope a compliant healthcare AI project, book a consultation with dgm. General information, not clinical, regulatory or funding advice.